207 related articles for article (PubMed ID: 34541390)
21. Improved osseointegration of 3D printed Ti-6Al-4V implant with a hierarchical micro/nano surface topography: An in vitro and in vivo study.
Ren B; Wan Y; Liu C; Wang H; Yu M; Zhang X; Huang Y
Mater Sci Eng C Mater Biol Appl; 2021 Jan; 118():111505. PubMed ID: 33255064
[TBL] [Abstract][Full Text] [Related]
22. Dimethyl fumarate prevents osteoclastogenesis by decreasing NFATc1 expression, inhibiting of erk and p38 MAPK phosphorylation, and suppressing of HMGB1 release.
Nishioku T; Kawamoto M; Okizono R; Sakai E; Okamoto K; Tsukuba T
Biochem Biophys Res Commun; 2020 Sep; 530(2):455-461. PubMed ID: 32553625
[TBL] [Abstract][Full Text] [Related]
23. Adenoviral delivery of adiponectin ameliorates osteogenesis around implants in ovariectomized rats.
Yin G; Liu H; Li J; Liu Y; Liu X; Luo E
J Gene Med; 2019 Feb; 21(2-3):e3069. PubMed ID: 30609197
[TBL] [Abstract][Full Text] [Related]
24. Gastrodin inhibits osteoclastogenesis via down-regulating the NFATc1 signaling pathway and stimulates osseointegration in vitro.
Zhou F; Shen Y; Liu B; Chen X; Wan L; Peng D
Biochem Biophys Res Commun; 2017 Mar; 484(4):820-826. PubMed ID: 28161640
[TBL] [Abstract][Full Text] [Related]
25. Osteoblasts grown on microroughened titanium surfaces regulate angiogenic growth factor production through specific integrin receptors.
Raines AL; Berger MB; Schwartz Z; Boyan BD
Acta Biomater; 2019 Oct; 97():578-586. PubMed ID: 31349056
[TBL] [Abstract][Full Text] [Related]
26. Liraglutide, a glucagon-like peptide-1 receptor agonist, suppresses osteoclastogenesis through the inhibition of NF-κB and MAPK pathways via GLP-1R.
Li Z; Li S; Wang N; Xue P; Li Y
Biomed Pharmacother; 2020 Oct; 130():110523. PubMed ID: 32702632
[TBL] [Abstract][Full Text] [Related]
27. Dual effect of WIN-34B on osteogenesis and osteoclastogenesis in cytokine-induced mesenchymal stem cells and bone marrow cells.
Seo BK; Ryu HK; Park YC; Huh JE; Baek YH
J Ethnopharmacol; 2016 Dec; 193():227-236. PubMed ID: 27401292
[TBL] [Abstract][Full Text] [Related]
28. Pmepa1 induced by RANKL-p38 MAPK pathway has a novel role in osteoclastogenesis.
Funakubo N; Xu X; Kukita T; Nakamura S; Miyamoto H; Kukita A
J Cell Physiol; 2018 Apr; 233(4):3105-3118. PubMed ID: 28802000
[TBL] [Abstract][Full Text] [Related]
29. Preliminary study of the homeostatic regulation of osseointegration by nanotube topology.
Chen T; Ren M; Li Y; Jing Z; Xu X; Liu F; Mo D; Zhang W; Zeng J; Zhang H; Ji P; Yang S
Mater Today Bio; 2024 Jun; 26():101038. PubMed ID: 38638704
[TBL] [Abstract][Full Text] [Related]
30. Urokinase receptor mediates osteoclastogenesis via M-CSF release from osteoblasts and the c-Fms/PI3K/Akt/NF-κB pathway in osteoclasts.
Kalbasi Anaraki P; Patecki M; Tkachuk S; Kiyan Y; Haller H; Dumler I
J Bone Miner Res; 2015 Feb; 30(2):379-88. PubMed ID: 25196912
[TBL] [Abstract][Full Text] [Related]
31. RGS18 acts as a negative regulator of osteoclastogenesis by modulating the acid-sensing OGR1/NFAT signaling pathway.
Iwai K; Koike M; Ohshima S; Miyatake K; Uchiyama Y; Saeki Y; Ishii M
J Bone Miner Res; 2007 Oct; 22(10):1612-20. PubMed ID: 17576169
[TBL] [Abstract][Full Text] [Related]
32. In vivo monitoring of the bone healing process around different titanium alloy implant surfaces placed into fresh extraction sockets.
Colombo JS; Satoshi S; Okazaki J; Crean SJ; Sloan AJ; Waddington RJ
J Dent; 2012 Apr; 40(4):338-46. PubMed ID: 22307025
[TBL] [Abstract][Full Text] [Related]
33. BMP2 immune complexes promote new bone formation by facilitating the direct contact between osteoclasts and osteoblasts.
Xu Y; Yang Y; Hua Z; Li S; Yang Z; Liu Q; Fu G; Ji P; Wu Q
Biomaterials; 2021 Aug; 275():120890. PubMed ID: 34130144
[TBL] [Abstract][Full Text] [Related]
34. Regulation of mesenchymal stem cell differentiation on microstructured titanium surfaces by semaphorin 3A.
Lotz EM; Berger MB; Boyan BD; Schwartz Z
Bone; 2020 May; 134():115260. PubMed ID: 32028017
[TBL] [Abstract][Full Text] [Related]
35. A strontium-incorporated nanoporous titanium implant surface for rapid osseointegration.
Zhang W; Cao H; Zhang X; Li G; Chang Q; Zhao J; Qiao Y; Ding X; Yang G; Liu X; Jiang X
Nanoscale; 2016 Mar; 8(9):5291-301. PubMed ID: 26881868
[TBL] [Abstract][Full Text] [Related]
36. miR-128 plays a critical role in murine osteoclastogenesis and estrogen deficiency-induced bone loss.
Shen G; Ren H; Shang Q; Zhang Z; Zhao W; Yu X; Tang J; Yang Z; Liang D; Jiang X
Theranostics; 2020; 10(10):4334-4348. PubMed ID: 32292498
[TBL] [Abstract][Full Text] [Related]
37. Activated T lymphocytes suppress osteoclastogenesis by diverting early monocyte/macrophage progenitor lineage commitment towards dendritic cell differentiation through down-regulation of receptor activator of nuclear factor-kappaB and c-Fos.
Grcević D; Lukić IK; Kovacić N; Ivcević S; Katavić V; Marusić A
Clin Exp Immunol; 2006 Oct; 146(1):146-58. PubMed ID: 16968409
[TBL] [Abstract][Full Text] [Related]
38. Microrough implant surface topographies increase osteogenesis by reducing osteoclast formation and activity.
Lossdörfer S; Schwartz Z; Wang L; Lohmann CH; Turner JD; Wieland M; Cochran DL; Boyan BD
J Biomed Mater Res A; 2004 Sep; 70(3):361-9. PubMed ID: 15293309
[TBL] [Abstract][Full Text] [Related]
39. Curcumin has immunomodulatory effects on RANKL-stimulated osteoclastogenesis in vitro and titanium nanoparticle-induced bone loss in vivo.
Yang C; Zhu K; Yuan X; Zhang X; Qian Y; Cheng T
J Cell Mol Med; 2020 Jan; 24(2):1553-1567. PubMed ID: 31845532
[TBL] [Abstract][Full Text] [Related]
40. Ameloblastin attenuates RANKL-mediated osteoclastogenesis by suppressing activation of nuclear factor of activated T-cell cytoplasmic 1 (NFATc1).
Chaweewannakorn W; Ariyoshi W; Okinaga T; Fujita Y; Maki K; Nishihara T
J Cell Physiol; 2019 Feb; 234(2):1745-1757. PubMed ID: 30105896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
